GEN (Gen Digital Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by GEN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Nora Denzel | Director | A | — | — |
| 2026-09-11 | Sherrese M Smith | Director | A | — | — |
| 2026-09-11 | Pavel Baudis | Director | MIXED | — | — |
| 2026-09-11 | Sue Barsamian | Director | MIXED | — | — |
| 2026-09-11 | EMILY HEATH | Director | A | — | — |
| 2026-09-11 | Ondrej Vlcek | Director | MIXED | — | — |
| 2026-09-11 | John C Chrystal | Director | A | — | — |
| 2026-09-11 | ERIC BRANDT | Director | MIXED | — | — |
| 2026-09-09 | BRYAN SEUK KO | COO, CLO and Secretary | Sell | — | — |
| 2026-09-03 | Ondrej Vlcek | Director | F | — | — |
| 2026-08-28 | Ondrej Vlcek | Director | Sell | — | — |
| 2026-08-27 | Ondrej Vlcek | Director | Sell | — | — |
| 2026-08-25 | Ondrej Vlcek | Director | Sell | — | — |
| 2026-08-21 | Ondrej Vlcek | Director | Sell | — | — |
| 2026-08-19 | Travis Michael Witteveen | Head of Products and Portfolio | MIXED | — | — |
| 2026-08-12 | Travis Michael Witteveen | Head of Products and Portfolio | Sell | — | — |
| 2025-06-03 | Frank E Dangeard | Director | F | — | — |
| 2025-05-19 | Vincent Pilette | CEO & President | A | — | — |
| 2025-05-19 | NATALIE MARIE DERSE | CFO | A | — | — |
| 2025-05-19 | BRYAN SEUK KO | CLO & Head Corp Aff | A | — | — |
| 2025-05-19 | Nora Denzel | Director | Sell | — | — |
| 2025-05-19 | John C Chrystal | Director | A | — | — |
| 2025-05-06 | NATALIE MARIE DERSE | CFO | MIXED | — | — |
| 2025-05-06 | BRYAN SEUK KO | CLO & Head Corp Aff | MIXED | — | — |
| 2025-05-06 | Vincent Pilette | CEO & President | MIXED | — | — |
| 2025-05-02 | BRYAN SEUK KO | CLO & Head Corp Aff | F | — | — |
| 2025-05-02 | NATALIE MARIE DERSE | CFO | F | — | — |
| 2025-05-02 | Vincent Pilette | CEO & President | F | — | — |
| 2025-05-02 | Ondrej Vlcek | Director | F | — | — |
| 2025-03-04 | Frank E Dangeard | Director | F | — | — |
| 2025-02-19 | Vincent Pilette | CEO & President | A | — | — |
| 2025-02-19 | NATALIE MARIE DERSE | CFO | MIXED | — | — |
| 2025-02-19 | BRYAN SEUK KO | CLO & Head Corp Aff | A | — | — |
| 2024-12-03 | Frank E Dangeard | Director | F | — | — |
| 2024-11-29 | BRYAN SEUK KO | CLO & Head Corp Aff | Sell | — | — |
| 2024-09-13 | Frank E Dangeard | Director | A | — | — |
| 2024-09-13 | Sherrese M Smith | Director | A | — | — |
| 2024-09-13 | Pavel Baudis | Director | F | — | — |
| 2024-09-13 | Frank E Dangeard | Director | F | — | — |
| 2024-09-13 | Sue Barsamian | Director | G | — | — |
| 2024-09-13 | ERIC BRANDT | Director | G | — | — |
| 2024-09-12 | Nora Denzel | Director | A | — | — |
| 2024-09-12 | EMILY HEATH | Director | A | — | — |
| 2024-09-12 | Sherrese M Smith | Director | A | — | — |
| 2024-09-12 | Frank E Dangeard | Director | A | — | — |
| 2024-09-12 | ERIC BRANDT | Director | A | — | — |
| 2024-09-12 | Pavel Baudis | Director | A | — | — |
| 2024-09-12 | Sue Barsamian | Director | A | — | — |
| 2024-09-12 | Peter A Feld | Director | A | — | — |
| 2024-08-21 | Vincent Pilette | CEO & President | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 49,856,175 | — |
| — | Director | 8,030,840 | — |
| — | Chairman, President and CEO | 4,732,127 | — |
| — | Director | 3,951,928 | — |
| — | Director | 3,641,201 | — |
| — | CEO | 2,826,698 | — |
| — | President and COO | 2,399,785 | — |
| — | CEO & President | 2,286,329 | — |
| — | EVP and CFO | 1,055,846 | — |
| — | Director | 926,298 | — |
| — | COO | 832,158 | — |
| — | SVP and General Counsel | 778,370 | — |
| — | EVP, CFO | 771,280 | — |
| — | COO, CLO and Secretary | 744,262 | — |
| — | Director | 741,601 | — |
| — | Director | 686,023 | — |
| — | EVP and Chief Nursing Officer | 656,799 | — |
| — | Head of Products and Portfolio | 634,985 | — |
| — | COO Int'l. Oper. & Rehab Svcs. | 623,821 | — |
| — | EVP, GC & Corporate Secretary | 552,575 | — |
| — | EVP and COO | 511,328 | — |
| — | General Counsel, CAO and Sec. | 470,801 | — |
| — | CFO | 456,678 | — |
| — | Director | 438,610 | — |
| — | Director | 428,610 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the GEN quote page; the site-wide leaderboard is on the insider transactions hub.